Mia M Gaudet1, Cari M Kitahara1, Christina C Newton1, Leslie Bernstein1, Peggy Reynolds1, Elisabete Weiderpass1, Aimée R Kreimer1, Gong Yang1, Hans-Olov Adami1, Michael C Alavanja1, Laura E Beane Freeman1, Heiner Boeing1, Julie Buring1, Anil Chaturvedi1, Yu Chen1, Aimee A D'Aloisio1, Michal Freedman1, Yu-Tang Gao1, J Michael Gaziano1, Graham G Giles1, Niclas Håkansson1, Wen-Yi Huang1, I-Min Lee1, Martha S Linet1, Robert J MacInnis1, Yikyung Park1, Anna Prizment1, Mark P Purdue1, Elio Riboli1, Kim Robien1, Dale P Sandler1, Catherine Schairer1, Howard D Sesso1, Xiao Ou Shu1, Emily White1, Alicja Wolk1, Yong-Bing Xiang1, Anne Zelenuich-Jacquotte1, Wei Zheng1, Alpa V Patel1, Patricia Hartge1, Amy Berrington de González1, Susan M Gapstur1. 1. Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA, Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA, Cancer Prevention Institute of California, Berkeley, CA, USA, Department of Medical Epidemiology and Biostatistics, Karolinska Insitutet, Stockholm, Sweden, Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway, Department of Research, Cancer Registry of Norway, Oslo, Norway, Samfundet Folkhälsan, Helsinki, Finland, Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA, Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Germany, Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA, Department of Population Health and Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA Social & Scientific Systems, Durham, NC, USA, Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China, Division of Aging, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA, Veteran's' Affairs Boston Healthcare System, Boston, MA, USA, Cancer Epidemiology Centre, Cancer Council Victoria, and Centre for Epidemiology and Biostatistics, University of Melbourne, VIC, Australia, Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, Division of Public Health Sciences, School of Medicine, Washington Universi
Abstract
BACKGROUND: Associations between anthropometry and head and neck cancer (HNC) risk are inconsistent. We aimed to evaluate these associations while minimizing biases found in previous studies. METHODS: We pooled data from 1,941,300 participants, including 3760 cases, in 20 cohort studies and used multivariable-adjusted Cox proportional hazard regression models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association of anthropometric measures with HNC risk overall and stratified by smoking status. RESULTS: Greater waist circumference (per 5 cm: HR = 1.04, 95% CI 1.03-1.05, P-value for trend = <0.0001) and waist-to-hip ratio (per 0.1 unit: HR = 1.07, 95% CI 1.05-1.09, P-value for trend = <0.0001), adjusted for body mass index (BMI), were associated with higher risk and did not vary by smoking status (P-value for heterogeneity = 0.85 and 0.44, respectively). Associations with BMI (P-value for interaction = <0.0001) varied by smoking status. Larger BMI was associated with higher HNC risk in never smokers (per 5 kg/m(2): HR = 1.15, 95% CI 1.06-1.24, P-value for trend = 0.0006), but not in former smokers (per 5 kg/m(2): HR = 0.99, 95% CI 0.93-1.06, P-value for trend = 0.79) or current smokers (per 5 kg/m(2): HR = 0.76, 95% CI 0.71-0.82, P-value for trend = <0.0001). Larger hip circumference was not associated with a higher HNC risk. Greater height (per 5 cm) was associated with higher risk of HNC in never and former smokers, but not in current smokers. CONCLUSIONS: Waist circumference and waist-to-hip ratio were associated positively with HNC risk regardless of smoking status, whereas a positive association with BMI was only found in never smokers.
BACKGROUND: Associations between anthropometry and head and neck cancer (HNC) risk are inconsistent. We aimed to evaluate these associations while minimizing biases found in previous studies. METHODS: We pooled data from 1,941,300 participants, including 3760 cases, in 20 cohort studies and used multivariable-adjusted Cox proportional hazard regression models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association of anthropometric measures with HNC risk overall and stratified by smoking status. RESULTS: Greater waist circumference (per 5 cm: HR = 1.04, 95% CI 1.03-1.05, P-value for trend = <0.0001) and waist-to-hip ratio (per 0.1 unit: HR = 1.07, 95% CI 1.05-1.09, P-value for trend = <0.0001), adjusted for body mass index (BMI), were associated with higher risk and did not vary by smoking status (P-value for heterogeneity = 0.85 and 0.44, respectively). Associations with BMI (P-value for interaction = <0.0001) varied by smoking status. Larger BMI was associated with higher HNC risk in never smokers (per 5 kg/m(2): HR = 1.15, 95% CI 1.06-1.24, P-value for trend = 0.0006), but not in former smokers (per 5 kg/m(2): HR = 0.99, 95% CI 0.93-1.06, P-value for trend = 0.79) or current smokers (per 5 kg/m(2): HR = 0.76, 95% CI 0.71-0.82, P-value for trend = <0.0001). Larger hip circumference was not associated with a higher HNC risk. Greater height (per 5 cm) was associated with higher risk of HNC in never and former smokers, but not in current smokers. CONCLUSIONS: Waist circumference and waist-to-hip ratio were associated positively with HNC risk regardless of smoking status, whereas a positive association with BMI was only found in never smokers.
Authors: Mia M Gaudet; Alpa V Patel; Juzhong Sun; Janet S Hildebrand; Marjorie L McCullough; Amy Y Chen; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-01-04 Impact factor: 4.254
Authors: Mia M Gaudet; Andrew F Olshan; Shu-Chun Chuang; Julien Berthiller; Zuo-Feng Zhang; Jolanta Lissowska; David Zaridze; Deborah M Winn; Qingyi Wei; Renato Talamini; Neolilia Szeszenia-Dabrowska; Erich M Sturgis; Stephen M Schwartz; Peter Rudnai; Jose Eluf-Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Elena Matos; Alexandru Bucur; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Karl Kelsey; Rolando Herrero; Richard B Hayes; Silva Franceschi; Victor Wunsch-Filho; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Chu Chen; Xavier Castellsague; Simone Benhamou; Paolo Boffetta; Paul Brennan; Mia Hashibe Journal: Int J Epidemiol Date: 2010-02-01 Impact factor: 7.196
Authors: G David Batty; Martin J Shipley; David Gunnell; Rachel Huxley; Mika Kivimaki; Mark Woodward; Crystal Man Ying Lee; George Davey Smith Journal: Econ Hum Biol Date: 2009-06-28 Impact factor: 2.184
Authors: Heather A Ward; Petra A Wark; David C Muller; Annika Steffen; Mattias Johansson; Teresa Norat; Marc J Gunter; Kim Overvad; Christina C Dahm; Jytte Halkjær; Anne Tjønneland; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Sylvie Mesrine; Paul Brennan; Heinz Freisling; Kuanrong Li; Rudolf Kaaks; Antonia Trichopoulou; Pagona Lagiou; Salavatore Panico; Sara Grioni; Rosario Tumino; Paolo Vineis; Domenico Palli; Petra H M Peeters; H Bas Bueno-de-Mesquita; Elisabete Weiderpass; Antonio Agudo; Jose Ramón Quirós; Nerea Larrañaga; Eva Ardanaz; José María Huerta; María-José Sánchez; Göran Laurell; Ingegerd Johansson; Ulla Westin; Peter Wallström; Kathryn E Bradbury; Nicholas J Wareham; Kay-Tee Khaw; Clare Pearson; Heiner Boeing; Elio Riboli Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02-09 Impact factor: 4.254
Authors: Gundula Behrens; Thomas Gredner; Christian Stock; Michael F Leitzmann; Hermann Brenner; Ute Mons Journal: Dtsch Arztebl Int Date: 2018-09-03 Impact factor: 5.594
Authors: Giulia Battistini Conti; Rebeca Franco de Lima Oliveira; Ayodele Alves Amorim; Harley Francisco de Oliveira; Fernanda de Carvalho Panzeri Pires-de-Souza; Alexandra Mussolino de Queiroz Journal: Clin Oral Investig Date: 2022-05-19 Impact factor: 3.606
Authors: Alexander Gormley; Charlotte Richards; Francesca Spiga; Emily Gray; Joanna Hooper; Barry Main; Emma E Vincent; Rebecca Richmond; Julian Higgins; Mark Gormley Journal: BMJ Open Date: 2022-05-04 Impact factor: 3.006
Authors: Mark Gormley; Tom Dudding; Eleanor Sanderson; Richard M Martin; Steven Thomas; Jessica Tyrrell; Andrew R Ness; Paul Brennan; Marcus Munafò; Miranda Pring; Stefania Boccia; Andrew F Olshan; Brenda Diergaarde; Rayjean J Hung; Geoffrey Liu; George Davey Smith; Rebecca C Richmond Journal: Nat Commun Date: 2020-11-27 Impact factor: 14.919
Authors: Heinz Freisling; Melina Arnold; Isabelle Soerjomataram; Mark George O'Doherty; José Manuel Ordóñez-Mena; Christina Bamia; Ellen Kampman; Michael Leitzmann; Isabelle Romieu; Frank Kee; Konstantinos Tsilidis; Anne Tjønneland; Antonia Trichopoulou; Paolo Boffetta; Vassiliki Benetou; H B As Bueno-de-Mesquita; José María Huerta; Hermann Brenner; Tom Wilsgaard; Mazda Jenab Journal: Br J Cancer Date: 2017-04-25 Impact factor: 7.640